![Marina Bozilenko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marina Bozilenko
Director/Board Member at
ASCENTAGE PHARMA GROUP INTERNATIONAL
Net worth: 58 906 $ as of 2026-06-29
Profile
Marina S.
Bozilenko is the founder of Somatogen, Inc. Current jobs include President, Chief Executive Officer & Director at Biothea Pharma, Inc. since 2021; Independent Director at Talphera, Inc. since 2021; Director at Implicit Bioscience Ltd.; Director at SH Parent, Inc.; and Independent Non-Executive Director at Ascentage Pharma Group International Co., Ltd. since 2024.
Former jobs include President, Chief Executive Officer & Director at Allos Therapeutics, Inc. from 1994 to 2012; Chief Executive Officer & Director at Aerpio Pharmaceuticals, Inc. from 2017 to 2019; Senior Managing Director at Bear, Stearns & Co., Inc. from 2003 to 2008; Managing Director at Banc of America Securities LLC in 2003; Managing Director at Vector Securities LLC; Managing Director & Head-West Coast at Vector Securities International, Inc. from 1998 to 1999; Director at Olema Pharmaceuticals, Inc. from 2010 to 2020; Director at SynAct Pharma AB from 2021 to 2024; Principal at Kidd & Co. LLC from 2008 to 2010; MD & Senior MD-West Coast Healthcare Investment at Prudential Vector Healthcare Group from 1999 to 2000; and Strategic Advisor at William Blair & Co. LLC from 2021 to 2024.
Education includes undergraduate and graduate degrees from The University of Chicago, conferred in 1986 and 1987 respectively.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 10,472 ( 0% ) | 44 334 $ | 2026-06-29 | |
TALPHERA, INC. 0.03% | 2026-06-21 | 14,147 ( 0.03% ) | 14 571 $ | 2026-06-29 |
Marina Bozilenko active positions
| Companies | Position | Start |
|---|---|---|
| TALPHERA, INC. | Director/Board Member | 2021-03-30 |
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Board Member | 2024-11-24 |
SH Parent, Inc.
 SH Parent, Inc. Financial ConglomeratesFinance Provides investment services | Director/Board Member | - |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Chief Executive Officer | 2021-05-31 |
Implicit Bioscience Ltd.
 Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Director/Board Member | - |
Former positions of Marina Bozilenko
| Companies | Position | End |
|---|---|---|
| SYNACT PHARMA AB | Director/Board Member | 2024-02-26 |
William Blair & Co. LLC
 William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2023-12-31 |
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 2020-02-29 |
| AERPIO PHARMACEUTICALS | Chief Executive Officer | 2019-09-30 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Marina Bozilenko
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Develops specialty oxygen therapeutics | Health Technology |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kidd & Co. LLC
 Kidd & Co. LLC Investment ManagersFinance Kidd invests in lower end of middle market companies located in the United States with an EBITDA of less than USD 10 million. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for growth and buyout transactions. The firm takes controlling interest. | Finance |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Provides investment banking services | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prudential Vector Healthcare Group
 Prudential Vector Healthcare Group Investment ManagersFinance Provides investment banking services | Finance |
Vector Securities International, Inc.
 Vector Securities International, Inc. Investment Banks/BrokersFinance Security Brokers Dealers And Flotation Companies | Finance |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
SH Parent, Inc.
SH Parent, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
- Stock Market
- Insiders
- Marina Bozilenko
